Cargando…

A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy

SIMPLE SUMMARY: Oncolytic adenoviruses are genetically engineered to selectively replicate within cancer cells by exploiting their unique characteristics while sparing normal cells. However, adenoviruses generally require the coxsackie and adenovirus receptor (CAR) to enter the cells. This study inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Tao, Shah, Jaimin R., Phung, Abraham T., Larson, Christopher, Sanchez, Ana B., Aisagbonhi, Omonigho, Blair, Sarah L., Oronsky, Bryan, Trogler, William C., Reid, Tony, Kummel, Andrew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296131/
https://www.ncbi.nlm.nih.gov/pubmed/37370769
http://dx.doi.org/10.3390/cancers15123157
_version_ 1785063585148305408
author Dong, Tao
Shah, Jaimin R.
Phung, Abraham T.
Larson, Christopher
Sanchez, Ana B.
Aisagbonhi, Omonigho
Blair, Sarah L.
Oronsky, Bryan
Trogler, William C.
Reid, Tony
Kummel, Andrew C.
author_facet Dong, Tao
Shah, Jaimin R.
Phung, Abraham T.
Larson, Christopher
Sanchez, Ana B.
Aisagbonhi, Omonigho
Blair, Sarah L.
Oronsky, Bryan
Trogler, William C.
Reid, Tony
Kummel, Andrew C.
author_sort Dong, Tao
collection PubMed
description SIMPLE SUMMARY: Oncolytic adenoviruses are genetically engineered to selectively replicate within cancer cells by exploiting their unique characteristics while sparing normal cells. However, adenoviruses generally require the coxsackie and adenovirus receptor (CAR) to enter the cells. This study investigated the activity of an oncolytic adenovirus in tumors with low CAR expression. The results showed that 58% and 33% of the tumors treated with liposome-encapsulated virus and viruses without liposome encapsulation achieved complete remission, respectively. Microscopic tissue analysis shows that an increased inflammatory infiltrate inside the tumor microenvironment is key to achieving effective therapeutic results in tumors independent of CAR expression. In the bilateral tumor model, both unencapsulated and encapsulated viruses reduced local tumor growth. However, only encapsulated virus reduced growth in distant tumors. Encapsulated adenovirus demonstrated an increased inflammatory infiltrate, including CD-8 and NK cells in both the treated and untreated tumors, whereas unencapsulated virus demonstrated limited inflammatory infiltrate in both tumors. ABSTRACT: This study evaluated the in vivo therapeutic efficacy of oncolytic serotype 5 adenovirus TAV255 in CAR-deficient tumors. In vitro experiments were performed with cell lines that expressed different levels of CAR (HEK293, A549, CT26, 4T1, and MCF-7). Low CAR cells, such as CT26, were poorly transduced by Ad in vitro unless the adenovirus was encapsulated in liposomes. However, the CT26 tumor in an immune-competent mouse model responded to the unencapsulated TAV255; 33% of the tumors were induced into complete remission, and mice with complete remission rejected the rechallenge with cancer cell injection. Encapsulation of TAV255 improves its therapeutic efficacy by transducing more CT26 cells, as expected from in vitro results. In a bilateral tumor model, nonencapsulated TAV255 reduced the growth rate of the locally treated tumors but had no effect on the growth rate of the distant tumor site. Conversely, encapsulated TAV255-infected CT26 induced a delayed growth rate of both the primary injected tumor and the distant tumor, consistent with a robust immune response. In vivo, intratumorally injected unencapsulated adenoviruses infect CAR-negative cells with only limited efficiency. However, unencapsulated adenoviruses robustly inhibit the growth of CAR-deficient tumors, an effect that constitutes an ‘in situ vaccination’ by stimulating cytotoxic T cells.
format Online
Article
Text
id pubmed-10296131
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102961312023-06-28 A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy Dong, Tao Shah, Jaimin R. Phung, Abraham T. Larson, Christopher Sanchez, Ana B. Aisagbonhi, Omonigho Blair, Sarah L. Oronsky, Bryan Trogler, William C. Reid, Tony Kummel, Andrew C. Cancers (Basel) Article SIMPLE SUMMARY: Oncolytic adenoviruses are genetically engineered to selectively replicate within cancer cells by exploiting their unique characteristics while sparing normal cells. However, adenoviruses generally require the coxsackie and adenovirus receptor (CAR) to enter the cells. This study investigated the activity of an oncolytic adenovirus in tumors with low CAR expression. The results showed that 58% and 33% of the tumors treated with liposome-encapsulated virus and viruses without liposome encapsulation achieved complete remission, respectively. Microscopic tissue analysis shows that an increased inflammatory infiltrate inside the tumor microenvironment is key to achieving effective therapeutic results in tumors independent of CAR expression. In the bilateral tumor model, both unencapsulated and encapsulated viruses reduced local tumor growth. However, only encapsulated virus reduced growth in distant tumors. Encapsulated adenovirus demonstrated an increased inflammatory infiltrate, including CD-8 and NK cells in both the treated and untreated tumors, whereas unencapsulated virus demonstrated limited inflammatory infiltrate in both tumors. ABSTRACT: This study evaluated the in vivo therapeutic efficacy of oncolytic serotype 5 adenovirus TAV255 in CAR-deficient tumors. In vitro experiments were performed with cell lines that expressed different levels of CAR (HEK293, A549, CT26, 4T1, and MCF-7). Low CAR cells, such as CT26, were poorly transduced by Ad in vitro unless the adenovirus was encapsulated in liposomes. However, the CT26 tumor in an immune-competent mouse model responded to the unencapsulated TAV255; 33% of the tumors were induced into complete remission, and mice with complete remission rejected the rechallenge with cancer cell injection. Encapsulation of TAV255 improves its therapeutic efficacy by transducing more CT26 cells, as expected from in vitro results. In a bilateral tumor model, nonencapsulated TAV255 reduced the growth rate of the locally treated tumors but had no effect on the growth rate of the distant tumor site. Conversely, encapsulated TAV255-infected CT26 induced a delayed growth rate of both the primary injected tumor and the distant tumor, consistent with a robust immune response. In vivo, intratumorally injected unencapsulated adenoviruses infect CAR-negative cells with only limited efficiency. However, unencapsulated adenoviruses robustly inhibit the growth of CAR-deficient tumors, an effect that constitutes an ‘in situ vaccination’ by stimulating cytotoxic T cells. MDPI 2023-06-12 /pmc/articles/PMC10296131/ /pubmed/37370769 http://dx.doi.org/10.3390/cancers15123157 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dong, Tao
Shah, Jaimin R.
Phung, Abraham T.
Larson, Christopher
Sanchez, Ana B.
Aisagbonhi, Omonigho
Blair, Sarah L.
Oronsky, Bryan
Trogler, William C.
Reid, Tony
Kummel, Andrew C.
A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
title A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
title_full A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
title_fullStr A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
title_full_unstemmed A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
title_short A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
title_sort local and abscopal effect observed with liposomal encapsulation of intratumorally injected oncolytic adenoviral therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296131/
https://www.ncbi.nlm.nih.gov/pubmed/37370769
http://dx.doi.org/10.3390/cancers15123157
work_keys_str_mv AT dongtao alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT shahjaiminr alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT phungabrahamt alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT larsonchristopher alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT sanchezanab alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT aisagbonhiomonigho alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT blairsarahl alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT oronskybryan alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT troglerwilliamc alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT reidtony alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT kummelandrewc alocalandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT dongtao localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT shahjaiminr localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT phungabrahamt localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT larsonchristopher localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT sanchezanab localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT aisagbonhiomonigho localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT blairsarahl localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT oronskybryan localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT troglerwilliamc localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT reidtony localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy
AT kummelandrewc localandabscopaleffectobservedwithliposomalencapsulationofintratumorallyinjectedoncolyticadenoviraltherapy